Tonix Pharmaceuticals stock halted ahead of FDA approval news
LONDON - DCI Advisors Limited (DCI), an investment advisory firm, has confirmed the receipt of the second installment payment from Mr. Aristodemou as part of the sale of its interests in Aristo Developers. The transaction included a cash payment of €4,108,830, of which €908,830 was directly received by the company, and an additional €3,200,000 was placed into an escrow account. The escrow funds are intended to cover DCI’s share of any potential liabilities related to DCI Holdings Two Limited and its subsidiaries until the completion of the sale.
The payment is part of a larger deal where the final €6,100,000 is scheduled for payment on August 21, 2025, pending tax clearances in Cyprus. In return for the recent payment, DCI transferred 606 ordinary shares of DCI Holdings Two Limited, which holds Aristo Developers, to Mr. Aristodemou. This transfer reduces DCI’s holding in DCI H2 to 10.68% of the total ordinary shares. The remaining shares held by DCI in DCI H2 are slated to be transferred to Mr. Aristodemou upon the final payment, at which point DCI will make a subsequent announcement.
This move signifies a step forward in the transaction process, which began with an initial announcement on February 21, 2025. The escrow account serves as a financial safeguard, ensuring that DCI fulfills its obligations concerning any unforeseen liabilities that may arise from its previous holdings.
The financial details of the transaction were disclosed in accordance with the regulations of the London Stock Exchange (LON:LSEG), where DCI Advisors Ltd is listed. The information provided in this article is based on a press release statement issued by the company.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.